Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus

Published 12/08/2022, 20:19
Updated 12/08/2022, 21:10
© Reuters.  Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus
DCYHY
-
IX
-

New York officials have detected polio in the city's wastewater, suggesting the virus has been circulating in the local area.

What Happened? On Friday, New York State Health Commissioner Dr. Mary Bassett said city health officials are working to determine how much the polio virus has spread after it was detected in the city's wastewater. Bassett has called on all New York residents that have not been vaccinated for polio to do so immediately.

Related Link: Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak

Why It's Important: Most people who catch polio have no symptoms, but one out of every 25 people who contract the polio virus develop viral meningitis, an inflammation of the brain and spinal cord membranes. There is no cure for polio, and roughly one in 200 unvaccinated people who catch the virus become paralyzed.

The U.S. was declared polio-free in 1979, but travelers have occasionally brought the disease into the country throughout the years. Prior to 2022, the last confirmed U.S. case of polio occurred in 2013.

Related Link: Why This UnitedHealth (NYSE:UNH) Analyst Sees Upside Ahead Following Q2 Earnings

As of 2019, the CDC reported nearly 93% of U.S. children had received three or more doses of the polio vaccine by age 2. About 99% of children who receive the recommended vaccinations are protected from the virus.

Poliovirus is very contagious and spreads commonly through contact with the feces of an infected person and rarely through droplets from a sneeze or cough of an infected person.

Leading polio vaccine makers include GSK plc (NYSE: GSK) and Sanofi (EPA:SASY) SA (NASDAQ: SNY).

Benzinga's Take: GSK and Sanofi's stocks both traded lower on the week because of growing concerns over the negative financial impact of lawsuits related to heartburn medication Zantac. So far there has only been one confirmed case of polio in the U.S., but officials say the virus' presence in the New York City wastewater suggests there could be several hundred unconfirmed and asymptomatic cases in the area.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.